Jane Grimm - Kronos Worldwide Secretary
| KRO Stock | USD 11.70 0.09 0.78% |
Executive
Jane Grimm is Secretary of Kronos Worldwide
| Age | 52 |
| Address | 5430 LBJ Freeway, Dallas, TX, United States, 75240-2620 |
| Phone | 972 233 1700 |
| Web | https://kronostio2.com |
Kronos Worldwide Management Efficiency
The company has Return on Asset of 0.0305 % which means that on every $100 spent on assets, it made $0.0305 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.112 %, implying that it generated $0.112 on every 100 dollars invested. Kronos Worldwide's management efficiency ratios could be used to measure how well Kronos Worldwide manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to grow to -0.03. In addition to that, Return On Capital Employed is likely to grow to -0.04. At this time, Kronos Worldwide's Other Current Assets are very stable compared to the past year. As of the 22nd of November 2024, Debt To Assets is likely to grow to 0.33, while Total Assets are likely to drop about 1.7 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jacques Rensburg | Gold Fields Ltd | N/A | |
| Jason Brown | Amtech Systems | N/A | |
| MSc MS | Gold Fields Ltd | 63 | |
| Louis Golato | Amtech Systems | 69 | |
| Edward Chiang | Madrigal Pharmaceuticals | N/A | |
| Thomas Mengel | Gold Fields Ltd | N/A | |
| Tzvet Ilarionova | Gold Fields Ltd | N/A | |
| Thomas Hare | Madrigal Pharmaceuticals | N/A | |
| Betty Larson | Merck Company | 48 | |
| Naseem BE | Gold Fields Ltd | 63 | |
| Tina Ventura | Madrigal Pharmaceuticals | N/A | |
| Ronald Filippo | Madrigal Pharmaceuticals | N/A | |
| Alex Howarth | Madrigal Pharmaceuticals | 55 | |
| Chris Gratias | Gold Fields Ltd | N/A | |
| Gerrit Lotz | Gold Fields Ltd | N/A | |
| Francois Swanepoel | Gold Fields Ltd | 51 | |
| Chirfi Guindo | Merck Company | 58 | |
| Aasutosh Dave | FormFactor | N/A | |
| Shai CPA | FormFactor | 52 | |
| PharmD MBA | Madrigal Pharmaceuticals | N/A | |
| Jacob Ricciardone | Gold Fields Ltd | N/A | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0305 |
Kronos Worldwide Leadership Team
Elected by the shareholders, the Kronos Worldwide's board of directors comprises two types of representatives: Kronos Worldwide inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kronos. The board's role is to monitor Kronos Worldwide's management team and ensure that shareholders' interests are well served. Kronos Worldwide's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kronos Worldwide's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bart Reichert, Vice President - Internal Audit | ||
| Patricia Kropp, Vice President Director of Global Human Resources | ||
| Kristin McCoy, Senior Vice President - Tax | ||
| Steven Eaton, Vice President and Director of Internal Control over Financial Reporting | ||
| Andrew Nace, Vice President General Counsel, Assistant Secretary | ||
| Clarence Brown, Vice President General Counsel, Assistant Secretary | ||
| Bryan Hanley, Vice President Treasurer | ||
| Cecil Moore, Independent Director | ||
| James Brown, Chief Financial Officer, Executive Vice President | ||
| Meredith Mendes, Independent Director | ||
| William Miller, Vice Resources | ||
| Alexis Thomason, Vice President General Counsel | ||
| Tim Hafer, Chief Financial Officer, Senior Vice President | ||
| Amy Samford, Executive President | ||
| Brian Christian, Executive Vice President, Chief Strategy Officer | ||
| James Buch, President, Chief Operating Officer | ||
| Courtney Riley, Senior Vice President - Health, Safety and Environment | ||
| John Harper, Independent Director | ||
| John Sunny, Senior Vice President, Chief Information Officer | ||
| Benjiman Corona, President Americas | ||
| Rainer Gruber, Executive Officer | ||
| Jane Grimm, Secretary | ||
| Benjamin Corona, President - Global Sales Management | ||
| Robert Graham, Vice Chairman of the Board, President and Chief Executive Officer | ||
| Loretta Feehan, Non-Executive Chairman of the Board | ||
| Janet Keckeisen, Vice President - Corporate Strategy and Investor Relations | ||
| Thomas Stafford, Independent Director | ||
| R Turner, Independent Director | ||
| Michael Simmons, Senior Vice President - Finance |
Kronos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kronos Worldwide a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0305 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 1.79 B | |||
| Shares Outstanding | 115.04 M | |||
| Shares Owned By Insiders | 81.26 % | |||
| Shares Owned By Institutions | 15.97 % | |||
| Number Of Shares Shorted | 918.03 K | |||
| Price To Earning | 17.40 X |
Pair Trading with Kronos Worldwide
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kronos Worldwide position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Worldwide will appreciate offsetting losses from the drop in the long position's value.Moving together with Kronos Stock
The ability to find closely correlated positions to Kronos Worldwide could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kronos Worldwide when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kronos Worldwide - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kronos Worldwide to buy it.
The correlation of Kronos Worldwide is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kronos Worldwide moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kronos Worldwide moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kronos Worldwide can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kronos Worldwide. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Worldwide guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Commodity Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Worldwide. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Worldwide listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.42) | Dividend Share 0.62 | Earnings Share 0.81 | Revenue Per Share 16.206 | Quarterly Revenue Growth 0.221 |
The market value of Kronos Worldwide is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Worldwide's value that differs from its market value or its book value, called intrinsic value, which is Kronos Worldwide's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Worldwide's market value can be influenced by many factors that don't directly affect Kronos Worldwide's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Worldwide's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Worldwide is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Worldwide's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.